Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Margolin
K. Margolin
Medicine
Renal cell carcinoma
Cancer research
Pathology
Bevacizumab
3
Papers
60
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II trial of gefitinib and pegylated interferon alfa 2b (PEG-IFN) in previously-treated renal cell carcinoma (RCC)
2009
Journal of Clinical Oncology
Derek Shek
J. Longmate
David I. Quinn
K. Margolin
Przemyslaw Twardowski
David R. Gandara
Chong-xian Pan
Primo N. Lara
Show All
Source
Cite
Save
Citations (0)
Tumor Biology, Detection and Therapy: 34th Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM, Pasadena, Calif., September 2006: Abstracts Supplement Issue: 'Tumor Biology 2006, Vol. 27, Suppl. 2'
2007
J. E. Shively
K. Margolin
H Fritsche
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of sunitinib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (mRCC)
2006
Journal of Clinical Oncology
B. I. Rini
Daniel J. George
M. D. Michaelson
J. E. Rosenberg
Ronald M. Bukowski
J.A. Sosman
Walter M. Stadler
K. Margolin
Thomas E. Hutson
Charles M. Baum
Show All
Source
Cite
Save
Citations (60)
1